Loading...
•
Jun 30, 2025
UFP Technologies Q2 2025 Earnings Report
UFP Technologies delivered record Q2 2025 results with strong revenue, net income, and adjusted EBITDA growth.
Key Takeaways
UFP Technologies posted a robust second quarter, achieving record sales and profitability metrics. Growth was driven by acquisitions and organic expansion in the MedTech segment. Gross margin slightly declined due to labor inefficiencies, but adjusted metrics reflected strong operational leverage.
Revenue grew to $151.2 million, a 37% increase from Q2 2024.
Net income rose to $17.2 million, or $2.21 per diluted share.
Adjusted EPS reached $2.50, up 27% year-over-year.
Adjusted EBITDA climbed to $31.8 million, a 33% increase.
Revenue by Segment
Forward Guidance
UFP Technologies remains optimistic about its growth trajectory with continued investment in capacity, recent acquisitions, and a strong sales pipeline, while acknowledging labor-related headwinds and broader macroeconomic uncertainty.
Positive Outlook
- Strong pipeline for internal and acquisition-driven growth
- Recent acquisitions expected to enhance MedTech capabilities
- Continued progress on Dominican Republic facility expansions
- MedTech segment showing consistent momentum
- SG&A efficiency improving through scaling
Challenges Ahead
- Labor inefficiencies affected gross margin in Q2
- Macroeconomic volatility could pressure margins
- Interest expense increased significantly due to higher debt
- Integration of acquisitions requires close management
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...